Korean Circ J.
2005 May;35(5):345-352. 10.4070/kcj.2005.35.5.345.
Gene Therapy for Heart Failure
- Affiliations
-
- 1Department of Internal Medicine, Chungbuk National University College of Medicine, Medical Research Institute, Chungbuk National University, Cheongju, Korea. mccho@cbnu.ac.kr
- KMID: 2227138
- DOI: http://doi.org/10.4070/kcj.2005.35.5.345
Abstract
- Heart failure is an important public medical problem in the developed countries. Although there are numerous and fascinating medicines given by physicians for the treatment of heart failure, the general 5 year survival rate for advanced heart failure is only about 50%. There are still many theoretical and practical problems to overcome before the application of gene therapy to cardiovascular disease becomes a reality in the future. With our increased knowledge on the development of gene delivery, vector systems, molecular basis of cardiac dysfunction, and the pathogenesis of heart failure at the cell level, gene therapy is emerging as a new therapeutic option for heart failure.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Recent Advances in Gene Therapy Targeted to Intracellular Calcium Transport for Heart Failure
- Novel Insights Into the Pathogenesis of Obesity-Related High Output Heart Failure From Gene Expression Profiling
- A Practical Way to Reduce Healthcare Costs in Patients With Heart Failure: Outpatient IV Diuretics Therapy
- Paradigm Shifts of Heart Failure Therapy: Do We Need Another Paradigm?
- New strategies in the treatment of hypertension
